July Stock 2021

Published on July 2021
Our “July Company Profile” Pacific Edge Limited had a very positive FY20 reporting 76% revenue growth and announcing commercial prospects in the US. The share price growth for 2019-20 was 289% and currently 2 Analysts following the stock predict a 12 month target price of $1.50. Pacific Edge Limited engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. The company was founded on February 27, 2001 and is headquartered in Dunedin, New Zealand.
Share this article with a friend!

Kickstart your mate's investing game.